Literature DB >> 20360128

Single-tube analysis of DNA methylation with silica superparamagnetic beads.

Vasudev J Bailey1, Yi Zhang, Brian P Keeley, Chao Yin, Kristen L Pelosky, Malcolm Brock, Stephen B Baylin, James G Herman, Tza-Huei Wang.   

Abstract

BACKGROUND: DNA promoter methylation is a signature for the silencing of tumor suppressor genes. Most widely used methods to detect DNA methylation involve 3 separate, independent processes: DNA extraction, bisulfite conversion, and methylation detection via a PCR method, such as methylation-specific PCR (MSP). This method includes many disconnected steps with associated losses of material, potentially reducing the analytical sensitivity required for analysis of challenging clinical samples.
METHODS: Methylation on beads (MOB) is a new technique that integrates DNA extraction, bisulfite conversion, and PCR in a single tube via the use of silica superparamagnetic beads (SSBs) as a common DNA carrier for facilitating cell debris removal and buffer exchange throughout the entire process. In addition, PCR buffer is used to directly elute bisulfite-treated DNA from SSBs for subsequent target amplifications. The diagnostic sensitivity of MOB was evaluated by methylation analysis of the CDKN2A [cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); also known as p16(INK4a)] promoter in serum DNA of lung cancer patients and compared with that of conventional methods.
RESULTS: Methylation analysis consisting of DNA extraction followed by bisulfite conversion and MSP was successfully carried out within 9 h in a single tube. The median pre-PCR DNA yield was 6.61-fold higher with the MOB technique than with conventional techniques. Furthermore, MOB increased the diagnostic sensitivity in our analysis of the CDKN2A promoter in patient serum by successfully detecting methylation in 74% of cancer patients, vs the 45% detection rate obtained with conventional techniques.
CONCLUSIONS: The MOB technique successfully combined 3 processes into a single tube, thereby allowing ease in handling and an increased detection throughput. The increased pre-PCR yield in MOB allowed efficient, diagnostically sensitive methylation detection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360128      PMCID: PMC3000409          DOI: 10.1373/clinchem.2009.140244

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  19 in total

Review 1.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

Authors:  M Frommer; L E McDonald; D S Millar; C M Collis; F Watt; G W Grigg; P L Molloy; C L Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 4.  The power and the promise of DNA methylation markers.

Authors:  Peter W Laird
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

5.  MethyLight: a high-throughput assay to measure DNA methylation.

Authors:  C A Eads; K D Danenberg; K Kawakami; L B Saltz; C Blake; D Shibata; P V Danenberg; P W Laird
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

6.  A simple method for the preparation of large quantities of pure plasmid DNA.

Authors:  G O Humphreys; G A Willshaw; E S Anderson
Journal:  Biochim Biophys Acta       Date:  1975-04-02

7.  Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis.

Authors:  A P Bird; E M Southern
Journal:  J Mol Biol       Date:  1978-01-05       Impact factor: 5.469

Review 8.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

9.  MS-qFRET: a quantum dot-based method for analysis of DNA methylation.

Authors:  Vasudev J Bailey; Hariharan Easwaran; Yi Zhang; Elizabeth Griffiths; Steven A Belinsky; James G Herman; Stephen B Baylin; Hetty E Carraway; Tza-Huei Wang
Journal:  Genome Res       Date:  2009-05-14       Impact factor: 9.043

10.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Authors:  J G Herman; A Merlo; L Mao; R G Lapidus; J P Issa; N E Davidson; D Sidransky; S B Baylin
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

View more
  25 in total

Review 1.  Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.

Authors:  Lane Lerner; Robert Winn; Alicia Hulbert
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

Review 3.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

Review 4.  The promise of methylation on beads for cancer detection and treatment.

Authors:  Angela A Guzzetta; Thomas R Pisanic Ii; Prateek Sharma; Joo Mi Yi; Alejandro Stark; Tza-Huei Wang; Nita Ahuja
Journal:  Expert Rev Mol Diagn       Date:  2014-09       Impact factor: 5.225

5.  Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.

Authors:  Bin Liu; Julio Ricarte Filho; Apurva Mallisetty; Cassandra Villani; Anastasia Kottorou; Kristen Rodgers; Chen Chen; Tomoaki Ito; Kyla Holmes; Nicole Gastala; Klara Valyi-Nagy; Odile David; Ron C Gaba; Christian Ascoli; Mary Pasquinelli; Lawrence E Feldman; Malek G Massad; Tza-Huei Wang; Ignacio Jusue-Torres; Enrico Benedetti; Robert A Winn; Malcolm V Brock; James G Herman; Alicia Hulbert
Journal:  Clin Cancer Res       Date:  2020-05-19       Impact factor: 12.531

Review 6.  Early detection: the impact of genomics.

Authors:  M C J van Lanschot; L J W Bosch; M de Wit; B Carvalho; G A Meijer
Journal:  Virchows Arch       Date:  2017-06-01       Impact factor: 4.064

7.  A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.

Authors:  Stéphanie L Gaillard; Marianna Zahurak; Anup Sharma; Jennifer N Durham; Kim A Reiss; Susan Sartorius-Mergenthaler; Melinda Downs; Nicole M Anders; Nita Ahuja; Michelle A Rudek; Nilofer Azad
Journal:  Cancer       Date:  2019-04-23       Impact factor: 6.860

Review 8.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events.

Authors:  Brian Keeley; Alejandro Stark; Thomas R Pisanic; Ruby Kwak; Yi Zhang; John Wrangle; Stephen Baylin; James Herman; Nita Ahuja; Malcolm V Brock; Tza-Huei Wang
Journal:  Clin Chim Acta       Date:  2013-08-01       Impact factor: 3.786

10.  Novel methylation biomarker panel for the early detection of pancreatic cancer.

Authors:  Joo Mi Yi; Angela A Guzzetta; Vasudev J Bailey; Stephanie R Downing; Leander Van Neste; Katherine B Chiappinelli; Brian P Keeley; Alejandro Stark; Alexander Herrera; Christopher Wolfgang; Emmanouil P Pappou; Christine A Iacobuzio-Donahue; Michael G Goggins; James G Herman; Tza-Huei Wang; Stephen B Baylin; Nita Ahuja
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.